Using AmpliSeq for Illumina Custom RNA panels for targeted gene expression profiling

2019/11/27

Jeff Tsai, a senior scientist in product development at Illumina, and his team set up a study to evaluate how the recently launched AmpliSeq™ for Illumina Custom RNA assay compares to qPCR for analyzing differential gene expression. Learn about their findings and discover the benefits of this targeted RNA-seq approach. For more information on AmpliSeq, please visit: https://www.illumina.com/products/by-brand/ampliseq.html Download the PDF: www.illumina.com/ampliseqRNA Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

この記事を共有します